Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.
暂无分享，去创建一个
F. Bosch | E. Montserrat | E. González-Barca | P. Abrisqueta | L. Escoda | N. Villamor | J. Delgado | Marcos González | M. Terol | J. Montoro | X. Calvo | I. Jarque | C. Ferrá | J. García-Marco | E. Abella | S. Ferrer | F. Carbonell | S. Bobillo | A. Muntañola | E. Monzó | Mireia Constants | Y. González